| Product NDC: | 16477-185 |
| Proprietary Name: | Donatussin |
| Non Proprietary Name: | Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride |
| Active Ingredient(s): | 12.5; 120; 5 mg/5mL; mg/5mL; mg/5mL & nbsp; Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16477-185 |
| Labeler Name: | Laser Pharmaceuticals, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110928 |
| Package NDC: | 16477-185-01 |
| Package Description: | 473 mL in 1 BOTTLE (16477-185-01) |
| NDC Code | 16477-185-01 |
| Proprietary Name | Donatussin |
| Package Description | 473 mL in 1 BOTTLE (16477-185-01) |
| Product NDC | 16477-185 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 20110928 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Laser Pharmaceuticals, LLC |
| Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 12.5; 120; 5 |
| Strength Unit | mg/5mL; mg/5mL; mg/5mL |
| Pharmaceutical Classes |